Indications
Therapeutic Asset Ratings
18,135 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Nemtabrutinib
B-Cell Chronic Lymphocytic Leukemia
Merck Sharp & Dohme LLC
P3
BB
(67)
Nepenthe
Cancer
M.D. Anderson Cancer Center
P3
BB
(67)
Nepenthe
Cancer-Related Condition
Instituto Nacional de Cancer, Brazil
P3
BB
(67)
Nepenthe
Hematopoietic And Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center
P3
BB
(67)
Niraparib
BRCA2-Related Cancer Predisposition
Qian Qin
P3
BB
(67)
Omaveloxolone
Friedreich Ataxia
Biogen
P3
BB
(67)
Opevesostat
Castration-Resistant Prostate Carcinoma
Merck Sharp & Dohme LLC
P3
BB
(67)
Opevesostat
Prostate Neoplasm
Merck Sharp & Dohme LLC
P3
BB
(67)
Orelabrutinib
Diffuse Large B-Cell Lymphoma
Ou Bai, MD/PHD
P3
BB
(67)
Orforglipron
Obesity Disorder
Eli Lilly and Company
P3
BB
(67)
Oxybutynin
Overactive Bladder
University of California, Davis
P3
BB
(67)
Palazestrant
Breast Cancer
Olema Pharmaceuticals, Inc.
P3
BB
(67)
Palazestrant
Estrogen-Receptor Positive Breast Cancer
Olema Pharmaceuticals, Inc.
P3
BB
(67)
Paltusotine
Carcinoid Tumor
Crinetics Pharmaceuticals Inc.
P3
BB
(67)
Paltusotine
Intestinal Neuroendocrine Tumor G1
Crinetics Pharmaceuticals Inc.
P3
BB
(67)
Paltusotine
Carcinoid Syndrome
Crinetics Pharmaceuticals Inc.
P3
BB
(67)
Paltusotine
Cecum Neuroendocrine Tumor G1
Crinetics Pharmaceuticals Inc.
P3
BB
(67)
Paltusotine
Ileal Neuroendocrine Tumor G1
Crinetics Pharmaceuticals Inc.
P3
BB
(67)
Paltusotine
Enterochromaffin Cell Serotonin-Producing Pancreatic Neuroendocrine Tumor
Crinetics Pharmaceuticals Inc.
P3
BB
(67)
Pirtobrutinib
Lymphoid Leukemia
Loxo Oncology, Inc.
P3
BB
(67)
Pitolisant
Prader-Willi Syndrome
Harmony Biosciences Management, Inc.
P3
BB
(67)
Pyrotinib
Hormone Receptor-Positive Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
P3
BB
(67)
Remibrutinib
Secondary Progressive Multiple Sclerosis
Moein Amin
P3
BB
(67)
Remibrutinib
Relapsing-Remitting Multiple Sclerosis
Moein Amin
P3
BB
(67)
Rezivertinib
Non-Small Cell Lung Carcinoma
The First Affiliated Hospital of Guangzhou Medical University
P3
BB
(67)
Showing 3201 to 3225 of 18,135 assets
Previous
Page 129 of 726
Next